These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9449645)

  • 21. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.
    Greene LA; Tischler AS
    Proc Natl Acad Sci U S A; 1976 Jul; 73(7):2424-8. PubMed ID: 1065897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and regulation of corticotropin-releasing hormone binding protein (CRH-BP) in rat adrenals.
    Chatzaki E; Margioris AN; Gravanis A
    J Neurochem; 2002 Jan; 80(1):81-90. PubMed ID: 11796746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. I: Effects of the common secretagogues.
    Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H
    Endocrinology; 1997 May; 138(5):1923-9. PubMed ID: 9112388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.
    Oldfield EH; Doppman JL; Nieman LK; Chrousos GP; Miller DL; Katz DA; Cutler GB; Loriaux DL
    N Engl J Med; 1991 Sep; 325(13):897-905. PubMed ID: 1652686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of noradrenergic and adrenergic cell groups of the brainstem and agouti-related protein-synthesizing neurons of the arcuate nucleus to neuropeptide-y innervation of corticotropin-releasing hormone neurons in hypothalamic paraventricular nucleus of the rat.
    Füzesi T; Wittmann G; Liposits Z; Lechan RM; Fekete C
    Endocrinology; 2007 Nov; 148(11):5442-50. PubMed ID: 17690163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of corticotropin-releasing hormone and dexamethasone on proopiomelanocortin messenger RNA level in human corticotroph adenoma cells in vitro.
    Suda T; Tozawa F; Yamada M; Ushiyama T; Tomori N; Sumitomo T; Nakagami Y; Demura H; Shizume K
    J Clin Invest; 1988 Jul; 82(1):110-4. PubMed ID: 2839542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of hypophysectomy on corticotropin-releasing hormone and adrenocorticotropin immunoreactivities in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Markowska A; Nussdorfer GG
    Mol Cell Neurosci; 1994 Aug; 5(4):345-9. PubMed ID: 7804604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphologic and cytochemical properties of a clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.
    Tischler AS; Greene LA
    Lab Invest; 1978 Aug; 39(2):77-89. PubMed ID: 682602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of differentiation on neuropeptide-Y receptors and responses in rat pheochromocytoma cells.
    DiMaggio DA; Farah JM; Westfall TC
    Endocrinology; 1994 Feb; 134(2):719-27. PubMed ID: 8299567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease.
    Nieman LK; Cutler GB; Oldfield EH; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1989 Jul; 69(1):165-9. PubMed ID: 2543689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticotropin-releasing hormone receptor expression on normal and tumorous human adrenocortical cells.
    Willenberg HS; Haase M; Papewalis C; Schott M; Scherbaum WA; Bornstein SR
    Neuroendocrinology; 2005; 82(5-6):274-81. PubMed ID: 16721033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nerve growth factor and K-252a increase catecholamine release from PC12 cells.
    Nikodijevic B; Creveling CR; Koizumi S; Guroff G
    J Neurosci Res; 1990 Jul; 26(3):288-95. PubMed ID: 2118962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cushing's syndrome secondary to ectopic corticotropin-releasing hormone-adrenocorticotropin secretion.
    Schteingart DE; Lloyd RV; Akil H; Chandler WF; Ibarra-Perez G; Rosen SG; Ogletree R
    J Clin Endocrinol Metab; 1986 Sep; 63(3):770-5. PubMed ID: 3525603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide and interleukin-1beta mediate noradrenergic induced corticotrophin-releasing hormone release in organotypic cultures of rat paraventricular nucleus.
    Hsieh CH; Li HY; Chen JC
    Neuroscience; 2010 Feb; 165(4):1191-202. PubMed ID: 20004705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epinephrine synthesis in the PC12 pheochromocytoma cell line.
    Byrd JC; Hadjiconstantinou M; Cavalla D
    Eur J Pharmacol; 1986 Aug; 127(1-2):139-42. PubMed ID: 3758174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.